Erlotinib-Impurities | Pharmaffiliates

erlotinib

An orally active tyrosine kinase inhibitor, Erlotinib is an anti cancer drug. It acts on the epidermal growth factor receptor (EGFR) and it is used for the treatment of several types of cancer like lung cancer, pancreatic cancer etc. Reference standards of Erlotinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline (BSC)
    [catalogue_number] => PA BSC 01405486
    [category_ids] => ,169,
    [chemical_name] => 
    [weight] => 312.75
    [form] => C14H17ClN2O4
    [cas] => 183322-18-1
    [pslug] => 183322-18-1-4-chloro-6-7-bis-2-methoxyethoxy-quinazoline-bsc-pabsc01405486
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA BSC 01405486

4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline (BSC)


  • Catalogue No.:PA BSC 01405486

  • CAS :

    183322-18-1

  • Molecular Formula : C14H17ClN2O4

  • Molecular Weight : 312.75